Onconetix, Inc. - ONCO

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2025 · Q2 2025
Value (USD)
Total reported value ($000)
$301K
QoQ value delta ($000)
+$260K (+634.15%)
Implied price effect (QoQ)
-32.25%
Shares
Total shares
97,657
QoQ shares delta
+88,645 (+983.63%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ONCO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2025)

Top 25 only Full list
Early Q1 2026 data: only 5 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
DRW Securities, LLC 192 61,784 0.0%
CITADEL ADVISORS LLC 48 15,633 0.0%
Pacific Capital Wealth Advisors, Inc. 40 13,000 0.01%
UBS Group AG 17 5,506 0.0%
Tower Research Capital LLC (TRC) 4 1,568 0.0%
BANK OF AMERICA CORP /DE/ 0 11 0.0%
DANSKE BANK A/S 0 1 0.0%
SBI Securities Co., Ltd. 0 154 0.0%